Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 Patients

Background: Measurable/minimal residual disease (MRD) status is suggested as a powerful indicator of clinical-outcome in T-cell lymphoblastic leukemia/lymphoma (T-ALL). Contrary to B-cell ALL, reports on T-ALL MRD are limited and mostly based on molecular methods, mainly from developed countries. Mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tembhare, Prashant R., Narula, Gaurav, Khanka, Twinkle, Ghogale, Sitaram, Chatterjee, Gaurav, Patkar, Nikhil V., Prasad, Maya, Badrinath, Yajamanam, Deshpande, Nilesh, Gudapati, Pratyusha, Verma, Shefali, Sanyal, Mahima, Kunjachan, Florence, Mangang, Gunit, Gujral, Sumeet, Banavali, Shripad, Subramanian, Papagudi G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193086/
https://www.ncbi.nlm.nih.gov/pubmed/32391267
http://dx.doi.org/10.3389/fonc.2020.00577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193086/
https://www.ncbi.nlm.nih.gov/pubmed/32391267
http://dx.doi.org/10.3389/fonc.2020.00577

Ejemplares similares